PKC signaling inhibits osteogenic differentiation through the regulation of Msx2 function

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 8, 2012, Pages 1225-1232

  Jeong, Hyung Min ^a   Jin, Yun Hye ^a   Choi, You Hee ^a   Yum, Jinah ^b   Choi, Joong Kook ^c   Yeo, Chang Yeol ^b   Lee, Kwang Youl ^a  

^a Chonnam National University   (South Korea)

^b Ewha Womans University   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

Author keywords

Msx2; Osteoblast differentiation; PKC; Protein stability; Runx2

Indexed keywords

PROTEIN KINASE C; PROTEIN KINASE C BETA; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HALF LIFE TIME; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION; HALF-LIFE; HOMEODOMAIN PROTEINS; HUMANS; MICE; OSTEOGENESIS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UBIQUITINATION;

EID: 84862243962     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.05.018     Document Type: Article

References (36)

1. Lampasso J.D., Chen W., Marzec N. The expression profile of PKC isoforms during MC3T3-E1 differentiation. Int. J. Mol. Med. 2006, 17:1125-1131.
2. Migliaccio S., Bernardini S., Wetsel W.C., Korach K.S., Faraggiana T., Teti A. Protein kinase C modulates estrogen receptors in differentiated osteoblastic cells in vitro. Steroids 1998, 63:352-354.
3. Longo M., Peruzzi B., Fortunati D., De Luca V., Denger S., Caselli G., Migliaccio S., Teti A. Modulation of human estrogen receptor alpha F promoter by a protein kinase C/c-Src-dependent mechanism in osteoblast-like cells. J. Mol. Endocrinol. 2006, 37:489-502.
4. Richardson J.A., Amantea C.M., Kianmahd B., Tetradis S., Lieberman J.R., Hahn T.J., Parhami F. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway. J. Cell. Biochem. 2007, 100:1131-1145.
5. Boguslawski G., Hale L.V., Yu X.P., Miles R.R., Onyia J.E., Santerre R.F., Chandrasekhar S. Activation of osteocalcin transcription involves interaction of protein kinase A- and protein kinase C-dependent pathways. J. Biol. Chem. 2000, 275:999-1006.
6. Miao D., Tong X.K., Chan G.K., Panda D., McPherson P.S., Goltzman D. Parathyroid hormone-related peptide stimulates osteogenic cell proliferation through protein kinase C activation of the Ras/mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 2001, 276:32204-32213.
7. Swarthout J.T., Doggett T.A., Lemker J.L., Partridge N.C. Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent. J. Biol. Chem. 2001, 276:7586-7592.
8. Park K.H., Han D.I., Rhee Y.H., Jeong S.J., Kim S.H., Park Y.G. Protein kinase C betaII and delta/theta play critical roles in bone morphogenic protein-4-stimulated osteoblastic differentiation of MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 2010, 403:7-12.
9. Tang C.H., Yang R.S., Huang T.H., Liu S.H., Fu W.M. Enhancement of fibronectin fibrillogenesis and bone formation by basic fibroblast growth factor via protein kinase C-dependent pathway in rat osteoblasts. Mol. Pharmacol. 2004, 66:440-449.
10. Nakura A., Higuchi C., Yoshida K., Yoshikawa H. PKCalpha suppresses osteoblastic differentiation. Bone 2011, 48:476-484.
11. Kim H.J., Kim J.H., Bae S.C., Choi J.Y., Ryoo H.M. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J. Biol. Chem. 2003, 278:319-326.
12. Costessi A., Pines A., D'Andrea P., Romanello M., Damante G., Cesaratto L., Quadrifoglio F., Moro L., Tell G. Extracellular nucleotides activate Runx2 in the osteoblast-like HOBIT cell line: a possible molecular link between mechanical stress and osteoblasts' response. Bone 2005, 36:418-432.
13. Jabs E.W., Muller U., Li X., Ma L., Luo W., Haworth I.S., Klisak I., Sparkes R., Warman M.L., Mulliken J.B., Snead M.L., Maxson R. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993, 75:443-450.
14. Wilkie A.O., Tang Z., Elanko N., Walsh S., Twigg S.R., Hurst J.A., Wall S.A., Chrzanowska K.H., Maxson R.E. Functional haploinsufficiency of the human homeobox gene MSX2 causes defects in skull ossification. Nat. Genet. 2000, 24:387-390.
15. Satokata I., Ma L., Ohshima H., Bei M., Woo I., Nishizawa K., Maeda T., Takano Y., Uchiyama M., Heaney S., Peters H., Tang Z., Maxson R., Maas R. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat. Genet. 2000, 24:391-395.
16. Cheng S.L., Shao J.S., Cai J., Sierra O.L., Towler D.A. Msx2 exerts bone anabolism via canonical Wnt signaling. J. Biol. Chem. 2008, 283:20505-20522.
17. Cheng S.L., Shao J.S., Charlton-Kachigian N., Loewy A.P., Towler D.A. MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J. Biol. Chem. 2003, 278:45969-45977.
18. Towler D.A., Rutledge S.J., Rodan G.A. Msx-2/Hox 8.1: a transcriptional regulator of the rat osteocalcin promoter. Mol. Endocrinol. 1994, 8:1484-1493.
19. Newberry E.P., Boudreaux J.M., Towler D.A. Stimulus-selective inhibition of rat osteocalcin promoter induction and protein-DNA interactions by the homeodomain repressor Msx2. J. Biol. Chem. 1997, 272:29607-29613.
20. Newberry E.P., Latifi T., Towler D.A. Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5. Biochemistry 1998, 37:16360-16368.
21. Kim Y.J., Lee M.H., Wozney J.M., Cho J.Y., Ryoo H.M. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J. Biol. Chem. 2004, 279:50773-50780.
22. Hassan M.Q., Javed A., Morasso M.I., Karlin J., Montecino M., van Wijnen A.J., Stein G.S., Stein J.L., Lian J.B. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol. Cell. Biol. 2004, 24:9248-9261.
23. Shirakabe K., Terasawa K., Miyama K., Shibuya H., Nishida E. Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5. Genes Cells 2001, 6:851-856.
24. Dodig M., Tadic T., Kronenberg M.S., Dacic S., Liu Y.H., Maxson R., Rowe D.W., Lichtler A.C. Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. Dev. Biol. 1999, 209:298-307.
25. Nishimura R., Kato Y., Chen D., Harris S.E., Mundy G.R., Yoneda T. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J. Biol. Chem. 1998, 273:1872-1879.
26. Carpenter A.C., Alexander J.S. Endothelial PKC delta activation attenuates neutrophil transendothelial migration. Inflamm. Res. 2008, 57:216-229.
27. Nakao S., Inoue D. Involvement of protein kinase C in IL-1beta-induced expression of cyclooxygenase-2 in human gingival fibroblasts. J. Oral Sci. 2009, 51:417-423.
28. Harada S., Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 2003, 423:349-355.
29. Bhat K.P., Greer S.F. Proteolytic and non-proteolytic roles of ubiquitin and the ubiquitin proteasome system in transcriptional regulation. Biochim. Biophys. Acta 2011, 1809:150-155.
30. Weissman A.M., Shabek N., Ciechanover A. The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nat. Rev. Mol. Cell Biol. 2011, 12:605-620.
31. Yoshizawa T., Takizawa F., Iizawa F., Ishibashi O., Kawashima H., Matsuda A., Endo N. Homeobox protein MSX2 acts as a molecular defense mechanism for preventing ossification in ligament fibroblasts. Mol. Cell. Biol. 2004, 24:3460-3472.
32. Yoon W.J., Cho Y.D., Cho K.H., Woo K.M., Baek J.H., Cho J.Y., Kim G.S., Ryoo H.M. The Boston-type craniosynostosis mutation MSX2 (P148H) results in enhanced susceptibility of MSX2 to ubiquitin-dependent degradation. J. Biol. Chem. 2008, 283:32751-32761.
33. Hamada S., Satoh K., Hirota M., Kimura K., Kanno A., Masamune A., Shimosegawa T. Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line. J. Cell. Physiol. 2007, 213:768-774.
34. Zhang H., Catron K.M., Abate-Shen C. A role for the Msx-1 homeodomain in transcriptional regulation: residues in the N-terminal arm mediate TATA binding protein interaction and transcriptional repression. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:1764-1769.
35. Hu G., Lee H., Price S.M., Shen M.M., Abate-Shen C. Msx homeobox genes inhibit differentiation through upregulation of cyclin D1. Development 2001, 128:2373-2384.
36. Li H., Weinstein I.B. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells. Cancer Res. 2006, 66:11399-11408.